The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Have we evaluated addiction treatment correctly? Implications from a chronic care perspective
Open accessAbstract
The excellent reviews of alcohol treatment outcomes and methods for evaluating and comparing treatment outcomes (Moyer, Finney & Swearingen 2002a; Moyer et al. 2002b; Miller & Wilbourne 2002) provide ample evidence of the methodological rigor and technological sophistication that have been developed in this field over the past 30 years. At the same time, these reviews have led me to question the conceptual underpinnings of addiction treatment and with it, addiction treatment outcome evaluation. In this regard, I have become interested in the analogies between addiction—both alcohol and drug addiction—and other chronic medical illnesses such as diabetes, hypertension and asthma (see O’Brien & McLellan 1996; McLellan et al. 2000). Literature reviews of treatment adherence and treatment relapse rates yielded rather surprising similarities between addictive disorders and these three, well-characterized chronic medical illnesses (see McLellan et al. 2000). For example, in virtually all cases where patients have been prescribed medications for these chronic illnesses, less than 50% continue to take those medications as prescribed; less than 30% of patients comply with prescribed behavioral changes such as weight loss, dietary restrictions on sugars or cholesterol or exercise regimens. When ‘relapse’ is defined as the re-emergence of symptoms requiring treatment in a hospital or an emergency room, the published studies suggest that 40–60% of patients with hypertension, diabetes or asthma relapse every year (see McLellan et al. 2000). It is important to note that all cases of addiction are not chronic. Many who meet diagnostic criteria for substance dependence recover completely, even without treatment. Others have long remissions following treatment. However, many of those who develop addiction disorders suffer multiple relapses following treatments and are thought to retain a continuing vulnerability to relapse for years or perhaps a lifetime. In this paper, I will continue the analogy between addiction and chronic medical illnesses, but not to further the debate on whether addiction really is a ‘disease’. Here, I focus on the separate—and I think under-appreciated question—of whether the assumptions underlying interventions for acute conditions or those for chronic conditions are more appropriate for the treatment addiction. Without any conclusion regarding the essence of addiction—a medical problem, a sin or a learned behavior—I offer two provocative implications that derive from thinking about addiction as a chronic condition. Any examination of the published effectiveness of treatments for chronic illnesses leads to the question of why they are considered to be so successful by the public at large. One answer is illustrated in Fig. 1. This figure shows the results of a typical trial of a new medication or a new intervention in the treatment of any chronic illness (the example here is hypertension). Severity of primary symptoms, blood pressure in this example, is measured along the y-axis. Pictured on the x-axis are measurement points prior to the start of treatment, three times during the course of the treatment and following the patient’s discontinuation of treatment. Evaluation of a hypothetical hypertension treatment. The effectiveness of the treatment evaluated in this hypothetical study is obvious. The first sign of effectiveness is the reduction in symptoms from before to during treatment. Although this treatment did not eliminate symptoms, there was a 75% improvement for the patient. There is a second way that the medical community and the public at large see effectiveness in this example: the re-emergence of symptoms following discontinuation of the treatment. Importantly, there is no expectation of cure in this evaluation: only that an effective treatment will reduce symptom severity while it is being administered. Indeed, the re-emergence of symptoms following discontinuation of a treatment has been used as a justification for strategies to retain patients in treatment. Consider a similar evaluation (Fig. 2), duplicating exactly the earlier results, except that it is the evaluation of an addiction treatment. The y-axis again shows symptom severity, perhaps days of cocaine use or number of standard drinks of alcohol in the past week. The x-axis shows the same measurement points. Here again, researchers, treatment providers and policy makers would all agree that the treatment was obviously not effective. Why? Because almost all addiction treatments (methadone maintenance and AA may be the only exceptions) are expected to produce lasting reduction in symptoms following termination of treatment. The reduction of symptoms during treatment is not adequate to the expectations underlying addiction treatment. In turn, almost all treatments have been evaluated six or 12 months following discharge from those treatments. From this perspective, the ‘disappointing’ return of symptoms following treatment discharge
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
Self-citation(1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.7 · Cited by 1,905
Moyer, A., Finney, J. W., Swearingen, C. E., & Vergun, P. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00018.x · Cited by 1,092
Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders
Miller, W. R., & Wilbourne, P. L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00019.x · Cited by 805
Myths about the treatment of addiction
O'Brien, C., & Thomas McLellan, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90409-2 · Cited by 512
The cost effectiveness of treatment for alcoholism: a first approximation
Holder, H., Longabaugh, R., Miller, W. R., & Rubonis, A. V. (1991) · Journal of Studies on Alcohol · doi:10.15288/jsa.1991.52.517 · Cited by 394
Inpatient alcoholism treatment: Who benefits?
Miller, W. R., & Hester, R. K. (1986) · American Psychologist · doi:10.1037//0003-066x.41.7.794 · Cited by 387
McLellan, A. T., Woody, G. E., Metzger, D., McKay, J., Durell, J., Alterman, A. I., & O'Brien, C. P. (1996) · The Milbank Quarterly · doi:10.2307/3350433 · Cited by 223
Self-citationThe cost-effectiveness of treatment for alcoholism: a second approximation.
Finney, J. W., & Monahan, S. C. (1996) · Journal of Studies on Alcohol · doi:10.15288/jsa.1996.57.229 · Cited by 186
McKay, J., Mclellan, A., Alterman, A., Cacciola, J., Rutherford, M., & O'Brien, C. (1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.152 · Cited by 96
Self-citation
Research works printed but not linked: 2
- 10.1037/0003-066X.41.7.794 · doi:10.1037/0003-066x.41.7.794 · Paper page
- Weisner C., 1997, Indicators of Chronic Health Conditions: Monitoring Community‐Level Delivery Systems, 260
Cited by
A "SMART" Design for Building Individualized Treatment Sequences
Lei, H., Nahum-Shani, I., Lynch, K., Oslin, D., & Murphy, S. A. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032511-143152 · Cited by 557
Relapse prevention for addictive behaviors
Hendershot, C. S., Witkiewitz, K., George, W. H., & Marlatt, G. A. (2011) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-6-17 · Cited by 467
Hser, Y.-I., Longshore, D., & Anglin, M. D. (2007) · Evaluation Review · doi:10.1177/0193841x07307316 · Cited by 360
Mindfulness-Based Relapse Prevention for substance craving
Witkiewitz, K., Bowen, S., Douglas, H., & Hsu, S. H. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.04.001 · Cited by 337
“Over the past decade, substance use disorder has been conceptualized as a chronic relapsing condition (McLellan, 2002; McLellan, McKay, Forman, Cacciola, & Kemp, 2005), where relapse has been variously defined as either the return to problematic substance use following treatment or as a process of…”
BackgroundA conceptual framework for drug treatment process and outcomes
Simpson, D. D. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.06.001 · Cited by 332
Metadata
- Authors
- McLellan, A. T.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2002-03
- Volume
- 97
- Issue
- 3
- Pages
- 249-252
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2137361412
- Cited by
- 306
- References
- 15
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. https://app.cochat.ai/papers/10.1046/j.1360-0443.2002.00127.x
- The paper
- McLellan, A. T. (2002). Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction. https://doi.org/10.1046/j.1360-0443.2002.00127.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.